Lipiodol Localization for Ground-glass-opacity Minimal Surgery

NACompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2017

Conditions
Pulmonary Lesion With Ground-glass-opacity
Interventions
PROCEDURE

Lipiodol

Lipiodol-guided lung localization technique

PROCEDURE

Hookwire

Hookwire-guided lung localization technique

DRUG

Lipiodol

Trial Locations (1)

120-752

Yonsei University Health System, Severance Hospital, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gangnam Severance Hospital

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Pusan National University Hospital

OTHER

collaborator

Korea University Anam Hospital

OTHER

collaborator

Chung-Ang University Hosptial, Chung-Ang University College of Medicine

OTHER

collaborator

Dankook University

OTHER

collaborator

Wonju Severance Christian Hospital

OTHER

lead

Severance Hospital

OTHER

NCT02180568 - Lipiodol Localization for Ground-glass-opacity Minimal Surgery | Biotech Hunter | Biotech Hunter